KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
7.05
+0.35 (5.22%)
Nov 6, 2024, 4:00 PM EST - Market closed
KALA BIO Employees
KALA BIO had 43 employees as of December 31, 2023. The number of employees increased by 9 or 26.47% compared to the previous year.
Employees
43
Change (1Y)
9
Growth (1Y)
26.47%
Revenue / Employee
n/a
Profits / Employee
-$900,395
Market Cap
32.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nortech Systems | 775 |
Celularity | 120 |
Surrozen | 42 |
AN2 Therapeutics | 41 |
Elevation Oncology | 29 |
Daré Bioscience | 26 |
Lipocine | 17 |
Dyadic International | 7 |
KALA News
- 5 months ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 10 months ago - KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 year ago - KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire